Bacterial complications of respiratory tract viral illness: A comprehensive evaluation

Journal of Infectious Diseases

Volumn 208, Issue 3, 2013, Pages 432-441

  Falsey, Ann R ^a,c   Becker, Kenneth L ^d,e   Swinburne, Andrew J ^c   Nylen, Eric S ^d,e   Formica, Maria A ^c   Hennessey, Patricia A ^c   Criddle, Mary M ^c   Peterson, Derick R ^b   Baran, Andrea ^b   Walsh, Edward E ^a,c  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c ROCHESTER GENERAL HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

bacterial infection; pneumonia; procalcitonin; virus

Indexed keywords

PROCALCITONIN;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BLOOD CULTURE; BRONCHITIS; CALCITONIN BLOOD LEVEL; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; CORONAVIRUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS; MIXED INFECTION; PATIENT ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SECONDARY INFECTION; SEROLOGY; SPUTUM CULTURE; URINALYSIS; VIRAL RESPIRATORY TRACT INFECTION;

BACTERIAL INFECTION; PNEUMONIA; PROCALCITONIN; VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; COINFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84880209465     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit190     Document Type: Article

References (32)

1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749-59.
2. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005; 41:345-51.
3. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human meta-pneumovirus, and influenza virus in older adults. J Infect Dis 2012; 206:56-62.
4. Rand KH, Rampersaud H, Houck HJ. Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP. J Clin Microbiol 2011; 49:2449-53.
5. Shiley KT, Lautenbach E, Lee I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol 2010; 31:1177-83.
6. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007; 95:1029-37.
7. Louria DE, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38:213-65.
8. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006; 6:303-12.
9. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010; 202:1287-95.
10. de Roux A, Ewig S, Garcia E, et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006; 27:795-800.
11. Talbot TR, Poehling KA, Hartert TV, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005; 118:285-91.
12. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 2011; 52 (Suppl 4):S296-304.
13. Muller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007; 7:10.
14. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36:941-52.
15. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171:1322-31.
16. Bacterial Respiratory Pathogen Reference Laboratory. http://www.vaccine. uab.edu/. Accessed 30 January 2013.
17. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 2010; 159:253-64.
18. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992; 40:115-9.
19. Walsh EE, Peterson DR, Falsey AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med 2008; 168:2489-96.
20. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 2003; 41:4160-5.
21. Gullsby K, Storm M, Bondeson K. Simultaneous detection of Chlamy-dophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. J Clin Microbiol 2008; 46:727-31.
22. Lu X, Holloway B, Dare RK, et al. Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Mi-crobiol 2008; 46:533-9.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of Royal Statistical Society 1995; 57:289.
24. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 InfluenzaBautista E, Chotpitayasunondh T, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
25. Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010; 134:235-43.
26. Miggins M, Hasan A, Hohmann S, et al. The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States. PLoS One 2011; 6:e18890.
27. Dhanoa A, Fang NC, Hassan SS, Kaniappan P, Rajasekaram G. Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J 2011; 8:501.
28. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012; 40:1487-98.
29. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquino-lone use. Infect Control Hosp Epidemiol 2005; 26:273-80.
30. Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest 2011; 139:1410-8.
31. Falsey AR, Becker KL, Swinburne AJ, et al. Utility of serum procalcito-nin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis 2012; 7:127-35.
32. Kherad O, Kaiser L, Bridevaux PO, et al. Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest 2010; 138:896-904.